Aug. 17, 2017
Trump’s Department of Justice Lets Mylan Off the Hook in EpiPen Settlement
Statement of Robert Weissman, President, Public Citizen
Mylan ripped off the government big time, and the U.S. Department of Justice is letting the company get away with it. Mylan misclassified EpiPen in such a way as to provide less generous discounts to Medicaid purchasers than the law requires. A government investigation concluded that as a result of the classification, Medicaid programs paid $1.27 billion more for EpiPens than they should have between 2006 and 2016.
Today’s shameful settlement is for barely a third of the amount of the rip-off, and it fails to include an admission of guilt – an appalling omission for a decade-long scheme that enabled Mylan to fatten its bottom line by more than a billion.